IL81221A0 - Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for preparing said proteins and pharmaceutical compositions containing them - Google Patents
Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for preparing said proteins and pharmaceutical compositions containing themInfo
- Publication number
- IL81221A0 IL81221A0 IL81221A IL8122187A IL81221A0 IL 81221 A0 IL81221 A0 IL 81221A0 IL 81221 A IL81221 A IL 81221A IL 8122187 A IL8122187 A IL 8122187A IL 81221 A0 IL81221 A0 IL 81221A0
- Authority
- IL
- Israel
- Prior art keywords
- proteins
- husi
- inhibitors
- biological activity
- type
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 230000004071 biological effect Effects 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 title abstract 2
- 238000010352 biotechnological method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863600571 DE3600571A1 (de) | 1986-01-10 | 1986-01-10 | Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL81221A0 true IL81221A0 (en) | 1987-08-31 |
Family
ID=6291649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL81221A IL81221A0 (en) | 1986-01-10 | 1987-01-09 | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for preparing said proteins and pharmaceutical compositions containing them |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4845076A (xx) |
| EP (1) | EP0232523B1 (xx) |
| JP (2) | JP2533869B2 (xx) |
| AT (1) | ATE88500T1 (xx) |
| AU (1) | AU604003B2 (xx) |
| CA (1) | CA1326216C (xx) |
| DE (2) | DE3600571A1 (xx) |
| DK (1) | DK11187A (xx) |
| ES (1) | ES2054612T3 (xx) |
| HU (1) | HU204888B (xx) |
| IE (1) | IE61526B1 (xx) |
| IL (1) | IL81221A0 (xx) |
| LT (1) | LTIP1753A (xx) |
| LV (1) | LV10490B (xx) |
| PT (1) | PT84089B (xx) |
| ZA (1) | ZA87141B (xx) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5871956A (en) * | 1984-12-06 | 1999-02-16 | Amgen Inc. | Recombinant methods for production of serine inhibitors and DNA sequences useful for same |
| US6291662B1 (en) | 1984-12-05 | 2001-09-18 | Amgen Inc. | Recombinant methods for production of serine protease inhibitors and DNA sequences |
| US5900400A (en) * | 1984-12-06 | 1999-05-04 | Amgen Inc. | Serine protease inhibitor analogs |
| US6132990A (en) * | 1984-12-06 | 2000-10-17 | Amgen Boulder Inc. | Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same |
| CA1340877C (en) * | 1987-12-28 | 2000-01-18 | Takashi Sugiyama | Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology |
| US5851983A (en) * | 1987-12-28 | 1998-12-22 | Teijin Limited | Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology |
| DE3841873A1 (de) * | 1988-12-13 | 1990-06-21 | Gruenenthal Gmbh | Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen |
| IT1235349B (it) * | 1988-12-23 | 1992-06-30 | Biodata Spa | Saggio immunologico per determinazioni in fase omogenea |
| US6869925B1 (en) * | 1992-09-09 | 2005-03-22 | Amgen Inc. | Inhibition of retrovirus infection |
| US6017880A (en) * | 1994-03-09 | 2000-01-25 | Amgen Inc. | Inhibition of retrovirus infection |
| US5900401A (en) * | 1994-03-23 | 1999-05-04 | Tokyo Tanabe Company Limited | Remedy for respiratory-tract viral disease |
| US5633227A (en) * | 1994-09-12 | 1997-05-27 | Miles, Inc. | Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| EP1400247A1 (en) * | 1999-07-01 | 2004-03-24 | Reprogen, Inc. | Treatment of endometriosis with antileukoprotease |
| US6544740B1 (en) * | 1999-07-01 | 2003-04-08 | Reprogen, Inc. | Treatment of endometriosis with antileukoprotease |
| US7247704B2 (en) | 2000-12-18 | 2007-07-24 | Arriva Pharmaceuticals, Inc. | Multifunctional protease inhibitors and their use in treatment of disease |
| AU2002325108A1 (en) * | 2001-08-27 | 2003-03-10 | Les Laboratoires Aeterna Inc. | Serine protease inhibitor and processes for the preparation thereof |
| GB2532488B (en) * | 2014-11-21 | 2019-07-31 | Univ Of The Western Cape | Use of AMP1 or AMP8 to diagnose HIV infection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986003519A1 (en) * | 1984-12-06 | 1986-06-19 | Synergen Biologicals, Inc. | Recombinant methods for production of serine protease inhibitors and dna sequences useful for same |
| JPS62501291A (ja) * | 1984-12-06 | 1987-05-21 | サイナ−ゲン バイオロジカルズ，インコ−ポレ−テツド | 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物 |
| EP0205555B2 (en) * | 1984-12-06 | 2002-04-10 | Amgen Inc. | Serine protease inhibitors and methods for isolation of same |
-
1986
- 1986-01-10 DE DE19863600571 patent/DE3600571A1/de not_active Withdrawn
- 1986-12-16 ES ES86117504T patent/ES2054612T3/es not_active Expired - Lifetime
- 1986-12-16 DE DE8686117504T patent/DE3688324D1/de not_active Expired - Fee Related
- 1986-12-16 EP EP86117504A patent/EP0232523B1/de not_active Expired - Lifetime
- 1986-12-16 AT AT86117504T patent/ATE88500T1/de not_active IP Right Cessation
-
1987
- 1987-01-08 ZA ZA87141A patent/ZA87141B/xx unknown
- 1987-01-09 PT PT84089A patent/PT84089B/pt not_active IP Right Cessation
- 1987-01-09 DK DK011187A patent/DK11187A/da not_active Application Discontinuation
- 1987-01-09 JP JP62003084A patent/JP2533869B2/ja not_active Expired - Lifetime
- 1987-01-09 IE IE5587A patent/IE61526B1/en not_active IP Right Cessation
- 1987-01-09 HU HU8779A patent/HU204888B/hu not_active IP Right Cessation
- 1987-01-09 CA CA000527073A patent/CA1326216C/en not_active Expired - Fee Related
- 1987-01-09 US US07/001,938 patent/US4845076A/en not_active Expired - Fee Related
- 1987-01-09 AU AU67452/87A patent/AU604003B2/en not_active Ceased
- 1987-01-09 IL IL81221A patent/IL81221A0/xx not_active IP Right Cessation
-
1993
- 1993-05-18 LV LVP-93-376A patent/LV10490B/en unknown
- 1993-12-31 LT LTIP1753A patent/LTIP1753A/xx unknown
-
1995
- 1995-04-10 JP JP7083931A patent/JP2659525B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2054612T3 (es) | 1994-08-16 |
| PT84089B (pt) | 1989-02-28 |
| JPS62259591A (ja) | 1987-11-11 |
| LV10490B (en) | 1995-10-20 |
| PT84089A (en) | 1987-02-01 |
| ATE88500T1 (de) | 1993-05-15 |
| JPH07300500A (ja) | 1995-11-14 |
| EP0232523B1 (de) | 1993-04-21 |
| IE870055L (en) | 1987-07-10 |
| US4845076A (en) | 1989-07-04 |
| HU204888B (en) | 1992-02-28 |
| ZA87141B (en) | 1987-08-26 |
| DK11187D0 (da) | 1987-01-09 |
| HUT43106A (en) | 1987-09-28 |
| JP2533869B2 (ja) | 1996-09-11 |
| JP2659525B2 (ja) | 1997-09-30 |
| LV10490A (lv) | 1995-02-20 |
| DK11187A (da) | 1987-07-11 |
| EP0232523A2 (de) | 1987-08-19 |
| DE3600571A1 (de) | 1987-08-06 |
| CA1326216C (en) | 1994-01-18 |
| IE61526B1 (en) | 1994-11-16 |
| DE3688324D1 (de) | 1993-05-27 |
| EP0232523A3 (en) | 1988-12-07 |
| LTIP1753A (en) | 1995-07-25 |
| AU6745287A (en) | 1987-07-16 |
| AU604003B2 (en) | 1990-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL81221A0 (en) | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for preparing said proteins and pharmaceutical compositions containing them | |
| RU94046367A (ru) | Днк, хозяйская клетка, способ получения белка, белок, фармацевтический препарат, антитело, применение антитела | |
| DE68929043D1 (de) | Für androgen-rezeptor-protein kodierende dna | |
| DK288183A (da) | Fremgangsmaade til fremstilling af et oligonucleotidt terapeutisk middel | |
| ATE113295T1 (de) | Tumornekrosefaktor, verfahren zu seiner herstellung, denselben enthaltende zusammensetzungen, dafür kodierende dns und diese dns verwendendes testverfahren. | |
| AU578050B2 (en) | Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them | |
| AU3368497A (en) | Human dnase i hyperactive variants | |
| MY101852A (en) | Tumor necrosis factor, methods for its preparation, containing it, dna encoding it and assay method using such dna. | |
| AU9058091A (en) | Preparation of nucleic acid samples | |
| IL88151A (en) | Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it | |
| GR3000944T3 (en) | Pharmaceutical composition containing thymus extract fractions | |
| ES2168361T3 (es) | Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo. | |
| NZ503235A (en) | Amino-terminally truncated RANTES as chemokine antagonists | |
| AU613583B2 (en) | Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity | |
| GR3007031T3 (xx) | ||
| FI896261A7 (fi) | Menetelmä proteiinin tai polypeptidin valmistamiseksi, polypeptidiä ko odaava DNA-sekvenssi, DNA-sekvenssin sisältämä mikro-organismi sekä po lypeptidi ja sen käyttö farmaseuttisena valmisteena | |
| HUP0001057A2 (hu) | A szarvasmarhafélék laktációjával összefüggő fehérje (CD14), az azt kódoló gén és a fehérje B-sejt-aktiválásban való alkalmazása | |
| IE890087L (en) | Recombinant human interleukin-1 alpha polypeptides | |
| AU1141695A (en) | Interferon-alpha/beta binding protein, its preparation and use | |
| AU2459188A (en) | Anticoagulative protein pp4-x, and its preparation and use | |
| UA5743C2 (uk) | Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання | |
| ATE55411T1 (de) | Menschliches antithrombin iii, dns sequenzen dafuer, expressions- und klonierungsvektoren die solche sequenzen enthalten und damit transformierte zellkulturen, verfahren zur expression von menschlichem antithrombin iii und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE65543T1 (de) | Dna-sequenzen des ebv-genoms, rekombinante dnamolek¨le, verfahren zur herstellung von ebvverwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |